KarmelSonix Limited (KSX) is pleased to announce the expansion of its distribution partner network throughout the Nordic Region and France.
In France, the Company has appointed Belateam SAS, a member of the Santeol Group, as its partner for all of France. The Belateam group has extensive experience in the respiratory and sleep field, offering healthcare solutions in the diagnosis, treatment and monitoring of patients suffering with conditions such as asthma, sleep disordered breathing and chronic obstructive pulmonary disease (COPD).Today Belateam SAS supplies CPAP, non-invasive ventilation and oxygen to the French marketplace. With this broad range of respiratory products currently being sold, the KarmelSonix technology dovetails perfectly into this respiratory portfolio.
In France, approximately 7% of the population suffers from some form of asthma. This equates to 3.5 million people.
The focus for the Belateam group will be to sell the PulmoTrack into the hospital environment, and the WheezoMeterTM into both the private patient market and doctor’s surgeries. The Belateam group in conjunction with KSX will be developing and implementing a continuous revenue model for the ambulatory monitoring device, the WHolterTM. The WHolterTM allows the physician to obtain data relating to wheeze detection, cough detection, and respiratory rate in the patient’s home environment.
In a further expansion to the Company’s global presence, the following distributors have been appointed in the Nordic region: Maribo Medica in Denmark, Somnivest in Sweden and Spira OY in Finland
Maribo Medica specialises in equipment for the diagnosis and treatment of respiratory conditions including sleep apnea, COPD, and ALS. The Company commenced operations in 1996 and currently has a clientele that includes most of the country’s hospitals as well as lung and sleep clinics. Maribo Medica represents major companies in Denmark, including ResMed and Embla. Somnivest in Sweden also has specialist expertise in the respiratory field. Spira OY of Finland is a leader in its field providing service and products in areas directly related to the KarmelSonix products such as lung function testing, sleep apnea, oxygen therapy and critical care.
KSX Managing Director for Europe and Asia Pacific, Paul Eisen said “Partnering with Belateam SAS now gives us access to France, one of the largest potential markets in Europe for KSX, with over 3.5 million people suffering from Asthma, and at least that number again suffering with Chronic Obstructive Pulmonary Disease (COPD). In relation to the Nordic region, the Company is delighted to have 3 partners with substantial, long term expertise in the respiratory field in their respective countries. All have excellent access to the pulmonologists and leading hospital clinics in their countries”.
Importantly, KarmelSonix now has secured European distribution coverage in most major markets, including UK, France, Germany, Italy, Nordics, Netherlands, Belgium, Czech Republic, Lithuania, Latvia, Greece and Romania.
http://www.traderdealer.com.au/Fundamentals/ksx
